Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy

Thyroid

Volumn 21, Issue 3, 2011, Pages 279-283

  Elbers, Laura ^a   Mourits, Maarten ^a   Wiersinga, Wilmar ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; ENDOCRINE OPHTHALMOPATHY; EYE SURGERY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PATIENT ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; THYROIDECTOMY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; HYPERTHYROIDISM; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 79952420410     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0181     Document Type: Article

References (17)

1. Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits M, Perros P, Boboridis K, Boschi A, Currò N, Daumerie C, Kahaly GJ, Krassas GE, Lane CM, Lazarus JH, Marinò M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM 2008 Consensus statement of the European Group on Graves' orbitopathy (EU-GOGO) onmanagement of GO. Eur J Endocrinol 158:273-285. (Pubitemid 351404990)
2. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78. (Pubitemid 28042269)
3. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A 1989 Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 321:1349-1352. (Pubitemid 19284190)
4. Tallstedt L, Lundell G, Terring O, Wallin G, Ljunggren J-G, Blomgren H, Taube A; Thyroid Study Group 1992 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 326:1733-1738.
5. Lai A, Sassi L, Compri E, Marino F, Sivelli P, Piantanida E, Tanda ML, Bartalena L 2010 Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study. J Clin Endocrinol Metab 95:1333-1337.
6. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Tørring O 2008 TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 158:69-75. (Pubitemid 351211042)
7. Marcocci C, Bruno-Bossio G, Manetti L, Tanda ML, Miccoli P, Iacconi P, Bartolomei MP, Nardi M, Pinchera A, Bartalena L 1999 The course of Graves' ophthalmopathy is not influenced by near-total thyroidectomy: a case-control study. Clin Endocrinol (Oxf) 51:503-506.
8. Jarhult J, Rudberg C, Larsson E, Selvander H, Sjovall K, Winsa B, Rastad J, Karlsson FA; TEO Study Group 2005 Graves' disease with moderate-severe endocrine ophthalmopathy-long term results of a prospective, randomized study of total or subtotal thyroid resection. Thyroid 15:1157-1164. (Pubitemid 41720722)
9. Menconi F, Marinò M, Pinchera A, Rocchi R, Mazzi B, Nardi M, Bartalena L, Marcocci C 2007 Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids. J Clin Endocrinol Metab 92:1653-1658. (Pubitemid 46997167)
10. Leo M, Latrofa F, Rocchi R, Mazzi B, Altea M, Megna L, Nardi M, Pinchera A, Marcocci C, Marinò M 2009 Long term outcome of Graves' ophthalmopathy (GO) treated with glucocorticoid (GC) following total thyroid ablation (TTA): follow-up of a randomized clinical trial. Abstract presented at the International Symposium on Graves' Orbitopathy, Amsterdam, Holland, October 29-30. Abstract no. 41.
11. Wiersinga WM, Prummel MF, Terwee CB 2004 Effects of Graves' ophthalmopathy on quality of life. J Endocrinol Invest 27:259-264. (Pubitemid 38607479)
12. Vos XG, Smit N, Endert E, Tijssen JGP, Wiersinga WM 2008 Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study. Clin Endocrinol (Oxf) 69:311-317. (Pubitemid 352009024)
13. Abraham P, Avenell A, McGeoch SC, Clark LF, Bevan JS 2010 Antithyroid drug regimen for treating Graves' hyperthyroidism. Cochrane Database Syst Rev 1: CD003420.
14. Azizi F, Ataie L, Hedayati M, Mehrabi Y, Sheikholeslami 2006 Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine. Eur J Endocrinol 152:695-701.
15. Mazza E, Carlini M, Flecchia D, Blatto A, Zuccarini O, Gamba S, Beninati S, Messina M 2008 Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study.. J Endocrinol Invest 31:866-872.
16. Perros P, Kendall-Taylor P, Neoh C, Frewin S, Dickinson J 2005 A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy. J Clin Endocrinol Metab 90:5321-5323. (Pubitemid 41262294)
17. Vannucchi G, Campi I, Covelli D, Dazzi D, Currò N, Simonetta S, Ratiglia R, Beck-Peccoz P, Salvi M 2009 Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis. J Clin Endocrinol Metab 94:3381-3386.